RecruitingT-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia
A Registry for People With T-cell Lymphoma
Eligible age
All ages
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.
Sponsor: Memorial Sloan Kettering Cancer Center
You may qualify if…
- ✓ Written informed consent
- ✓ Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.
- ✓ Pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma meeting one of the following diagnostic criterion (based on WHO classification and NCCN guidelines):
- ✓ T-cell prolymphocytic leukemia
- ✓ T-cell large granular lymphocytic leukemia
- ✓ Chronic lymphoproliferative disorder of NK cells
- ✓ Aggressive NK-cell leukemia
- ✓ Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoma of childhood
You may not qualify if…
- ✕ Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.
- ✕ Inability to collect prospective data, measure response, or perform adequate follow-up assessments in the clinical judgment of the treating physician. NOTE: Repository participation does not exclude participation in clinical trials, nor does existing clinical trial participation exclude enrollment in the study herein outlined.
Where it's recruiting
California
Duarte · San Diego · San Francisco · Stanford
Colorado
Aurora
Connecticut
New Haven
Florida
Miami · Tampa
Georgia
Atlanta
Illinois
Chicago
Massachusetts
Boston
Minnesota
Rochester
Missouri
St Louis
Nebraska
Omaha
New Jersey
Basking Ridge · Middletown
New York
Commack · Harrison · New York · Uniondale
Source: ClinicalTrials.gov · NCT05978141 · last updated 2026-05-20